EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets

Muhammad Rafehi iD, Franziska Tägl, Nike Sophia Arlt, Maria Neif, Katja Stefan iD, Wouroud Ismail Al-Khalil iD, Hauke Busch, Marius Möller, Jörg König iD, Vigneshwaran Namasivayam, Sven Marcel Stefan iD

ACS Pharmacology & Translational Science · 13.02.2026 · 9 (2) · 332-347

DOI: 10.1021/acsptsci.5c00430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 27.01.2026. Verfasst von Muhammad Rafehi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutscher Akademischer Austauschdienst, Deutsche Forschungsgemeinschaft, Universit??tsmedizin G??ttingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ABC transporterpolypharmacologypolyspecificityprivileged structuresolute carrierundruggability

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany.
  • Faculty of Medicine, University of Augsburg and University Hospital of Augsburg, Am Medizincampus 2, 86156 Augsburg, Germany.
  • Lübeck Institute of Experimental Dermatology (LIED), Medicinal Chemistry and Systems Polypharmacology, University of Lübeck and University Medical Center Schleswig-Holstein (UKSH), Ratzeburger Allee 160, 23538 Lübeck, G…
  • Department of Pathology, Rikshospitalet, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.
  • Lübeck Institute of Experimental Dermatology (LIED), Medical Systems Biology, University of Lübeck and University Medical Center Schleswig-Holstein (UKSH), Ratzeburger Allee 160, 23538 Lübeck, Germany.
  • Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

ORCID-Profile: Muhammad Rafehi, Katja Stefan, Wouroud Ismail Al-Khalil, Jörg König, Sven Marcel Stefan

Förderung

  • Deutscher Akademischer Austauschdienst
  • Deutsche Forschungsgemeinschaft
  • Universit??tsmedizin G??ttingen
  • Narodowym Centrum Nauki

Zitieren

APA

Rafehi, M., Tägl, F., Arlt, N. S., Neif, M., Stefan, K., Ismail Al-Khalil, W., Busch, H., Möller, M., König, J., Namasivayam, V., & Stefan, S. M. (2026). Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets. ACS Pharmacology & Translational Science, 9(2), 332-347. https://doi.org/10.1021/acsptsci.5c00430

Vancouver

Rafehi M, Tägl F, Arlt NS, Neif M, Stefan K, Ismail Al-Khalil W, et al. Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets. ACS Pharmacology & Translational Science. 2026;9(2):332-347. doi:10.1021/acsptsci.5c00430

BibTeX
@article{Rafehi2026,
  author = {Rafehi, Muhammad and Tägl, Franziska and Arlt, Nike Sophia and Neif, Maria and Stefan, Katja and Ismail Al-Khalil, Wouroud and Busch, Hauke and Möller, Marius and König, Jörg and Namasivayam, Vigneshwaran and Stefan, Sven Marcel},
  title = {Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {332--347},
  doi = {10.1021/acsptsci.5c00430}
}
Kostenlos starten →